NCT05827991Status unknown
A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia
A Randomized Controlled Trial of the Efficacy and Safety of 1565nm Non-ablative Fractional Laser on Treating Androgenic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Xijing Hospital
- Participants (registry)
- 75
- Start
- March 2022
- Primary completion
- December 2023
- Study completion
- December 2023
- Last registry update
- April 2023
- Countries
- China
Conditions studied: Androgenic Alopecia
Interventions: 1565nm Non-ablative Fractional Laser, 5% minoxidil external use, 1565nm Non-ablative Fractional Laser combined with 5% minoxidil
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.